D. Zhen

发表

Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification.

D. Simeone, E. Pratt, Robert W. Cowan, 2019, Analytical chemistry.

Ultra-low Input Circulating Tumor DNA Detection by MED-Amp in Early-Stage Pancreatic Cancer

D. Simeone, E. Pratt, A. Rhim, 2021, bioRxiv.

Phase 1b/2, open-label, dose-escalation and expansion trial of tucatinib in combination with trastuzumab with and without oxaliplatin-based chemotherapy or pembrolizumab in patients with unresectable or metastatic HER2+ gastrointestinal cancers (trial in progress).

T. Bekaii-Saab, M. Pishvaian, J. Strickler, 2022, Journal of Clinical Oncology.

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT‐01

K. Griffith, D. Mahalingam, D. Deming, 2022, Cancer.

Abstract LB-183: Metformin use does not increase survival of pancreatic cancer patients: A cautionary lesson

W. Bamlet, A. Oberg, G. Petersen, 2015 .

Combination immunotherapy for pancreatic cancer: challenges and future considerations

E. Chiorean, V. Pillarisetty, D. Zhen, 2022, Expert review of clinical immunology.

Hereditary ATTR amyloidosis: a single-institution experience with 266 patients

A. Dispenzieri, R. Kyle, M. Gertz, 2015, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Treatment of Cholesterol Embolization Syndrome in the Setting of an Acute Indication for Anticoagulation Therapy.

J. Lieske, J. Grande, Hidong Kim, 2014, Journal of medical cases.

Frequencies and geographic distributions of genetic mutations in transthyretin‐ and non‐transthyretin‐related familial amyloidosis

A. Dispenzieri, M. Gertz, S. Zeldenrust, 2015, Clinical genetics.

BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study

Michele L Cote, D. Seminara, L. Cannon-Albright, 2014, Genetics in Medicine.

Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma.

M. Reni, E. Chiorean, D. Zhen, 2018, Seminars in oncology.

A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer

Edward J. Kim, K. Griffith, K. Camphausen, 2016, Investigational New Drugs.

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

W. Bamlet, A. Oberg, G. Petersen, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan-associated dysarthria: A single institution case series with management implications in patients with gastrointestinal malignancies

M. Zalupski, V. Sahai, D. Zhen, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas

C. Pritchard, James O. Park, E. Chiorean, 2022, The oncologist.

The role of molecular testing in pancreatic cancer

E. Chiorean, D. Zhen, Ryan Nguyen, 2023, Therapeutic advances in gastroenterology.

A multicenter randomized phase II study of nivolumab in combination with gemcitabine/cisplatin or ipilimumab as first-line therapy for patients with advanced unresectable biliary tract cancer (BilT-01).

K. Griffith, D. Mahalingam, D. Deming, 2018 .

SWOG S2012: Randomized phase II/III trial of first line platinum/etoposide (P/E) with or without atezolizumab (NSC#783608) in patients (pts) with poorly differentiated extrapulmonary small cell neuroendocrine carcinomas (NEC).

I. Wistuba, E. Swisher, R. Kurzrock, 2022, Journal of Clinical Oncology.

DNA Damage Repair Defects and Survival Outcomes for Patients With Resected Pancreatic Ductal Adenocarcinoma

E. Swisher, K. Wong, E. Chiorean, 2021, Pancreas.

Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification

D. Simeone, E. Pratt, A. Rhim, 2018, bioRxiv.

Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study.

E. Chiorean, H. Greenlee, K. Guthrie, 2023, Contemporary clinical trials.